您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[沙利文]:医药研发外包服务行业研究报告 - 发现报告
当前位置:首页/行业研究/报告详情/

医药研发外包服务行业研究报告

医药生物2024-05-06沙利文福***
AI智能总结
查看更多
医药研发外包服务行业研究报告

5 2024 .......................................................................................................................4 ....................................................................................................5 1.1 / ..........................................................................................5 1.2 ......................................................5 1.3 &....................................6 1.4 ......................................................7 1.5 .........................................................................................................9 1.6 .............................................................10 1.7 CDEIND ...............................10 1.8 ......................................12 1.9 ....................................................................................12 1.10 ....................................................13 CRO .............................................................16 2.1 CRO ........................................................................16 2.1.1 .....................................................................................................17 2.1.2 .....................................................................................................18 2.2 CRO ..........................................................................................................24 2.3 CRO ..............................................................................25 2.4 CRO .....................................................26 2.5 CRO .....................................................27 2.6 CRO ...............................................................................................28 2.6.1..................................................28 2.6.2CRO30 2.6.3...........................................................................................31 2.6.4CDE33 2.6.5CDE33 2.6.6CRO2018-2030E34 2.6.7CRO35 2.6.8CRO35 2.6.9CRO36 2.6.10CRO38 2.6.11CO44 1961 45 2,000 1,000 10 54 10,000 50    5 2024 / CRO / 10 10 INDInvestigationalNewDrug CRO CRO CROContractResearchOrganization 20 70 CRO / 20 80 CRO 90CRO CRO 20 90 CRO 21 CRO CRO CRO CRO CRO CRO 2015 CRO CRO 1 2 CRO CRO SMO CRO 2026 CRO 2018539.1 2023 821.18.8% 1,064.5202320269.0% CRO 2018-2030 CRO 20182023CRO388.016.9% 848.3 CRO 2030 CRO 1,854.9CROCRO2023 CRO 442.4 2026 597.9 20232026CRO10.6% CRO 2018-2030E